MEI Pharma Inc.

Common Stock · USD · NASDAQ

LITST212

Price

$0.978

-2.21%

Cap

$8.48B

Earnings

—

30d Trend

-17.1%

0JW9

Loading chart data...

0 days · % change from startPowered by Brain47

VolatilityHigh

62% annualised over 90 days

BRAIN47 SIGNAL

VERY WEAK

Risk Level85

Quality24

Momentum19

Technical37

Fundamentals50

Raw weighted: 24×Macro 0.99 (−1%)=24

RISK

85/100

90d Volatility

61.5%High

ATR %

6.9%High daily moves

Max Drawdown (1Y)

-86.2%Volatile

QUALITY

24/100

ROE (avg)

-94.2%*Negative

Piotroski F-Score

4/9Average

Accruals

26.8%Accrual heavy

MOMENTUM

19/100

12-1M Momentum

-42.1%Strong downtrend

6-1M Momentum

-34.7%Negative

1M Return

-11.3%Sharp decline

Relative Strength

-0.1% vs sectorIn-line

TECHNICAL

37/100

RSI (14)

37.0Neutral

Price vs SMA200

-45.5%Bearish trend

MACD

-0.01Bearish momentum

Bollinger Band

7%Near lower band

SMA Cross

Golden CrossGolden Cross

Trend Quality (KER)

0.200Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 80%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months ★46

3-12 months22

1-5+ years31

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate MEI Pharma Inc. at 24/100 — a VERY WEAK reading on the Brain47 Signal. The strongest factor is fundamentals at 50/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

-11.3%

3 MONTHS

-9.7%

12 MONTHS

-53.4%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Fundamentals (50) and Technical (37) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 62%. I classify this as a speculative position — elevated volatility at 62% and smaller market cap define the opportunity.

speculativeScore: 24/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.